discussion and analysis for the year as at 31 December 2017, as follow Analysis of Financial Performance Full Year 2017 Revenues Revenues Accounting Year 2016 2017 THB Mn % (1) THB Mn % (1) Revenue from Sales

financial statements in Q2/2017 was THB 246.90 million, increasing THB 74.37 million from the same six-month period of the previous year due to increase in dividend received from subsidiaries from THB 8.02

Microsoft Word - ผลการดำเนินงาน_Q1_2561_ENG (Translated) May 14, 2018 Ref FSS 076/2018 Subject: The financial performance analysis of the first quarter of 2018 To The President The Stock Exchange of

2019 dividend payment of THB 1.0 per share paid from net profit, equal to 93% dividend payout ratio. *Net Profit = Net Profit attributable to owners of the parent Financial Performance for Q4’19 and FY19

million. Due to total revenues decreased of Baht 554.20 million mainly from brokerage fees decreased of Baht 282.56 million, Gain and return on financial instruments decreased of Baht 326.45 million and

received from long- term borrowings from a financial institution amount of THB 195 million and dividend payment amount of THB 417 million. -5- Financial Ratio Analysis Financial Rate 9 months In 2018 9

Results Details Financial Statements for the year ended 31 December 2017 31 December 2018 Change Million Baht % Million Baht % Million Baht % Service income 151.53 99.79% 153.89 99.10% 2.36 1.56% Other

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

Financial Statement of the year ended 2018 and Annual Report of the Board of Directors. 3) To consider and approve the appropriation of net profit as legal reserve and declaration of dividend payment for the

คำอธิบายและการวิเคราะห์ของฝ่ายจัดการ 22 February 2019 Re: To clarify the financial statements as of 31 December 2018 To: President The Stock Exchange of Thailand WHA Corporation Public Company